Millendo Therapeutics, Inc. Announces Executive Changes
June 28, 2018 at 08:00 am EDT
Millendo Therapeutics, Inc. announced the appointment of Ryan Zeidan, Ph.D., as Senior Vice President, Development. Prior to joining the company, Dr. Zeidan served as executive director, global project leader, at Celgene. Additionally, the company promoted Jeffery Brinza, J.D., to Chief Administrative Officer and General Counsel; Andrew Spencer, Ph.D., to Senior Vice President, Preclinical Research & Development and Thomas Hoover to Senior Vice President, Corporate Strategy.